Advanced search
Publication Cover
Future Cardiology Volume 6, 2010 - Issue 3
Submit an article Journal homepage
300
Views
0
CrossRef citations to date
0
Altmetric
Review

From Molecular Mechanisms of Cardiac Development to Genetic Substrate of Congenital Heart Diseases

Antonella Cecchetto1 University of PaduaPaduaItaly
,
Alessandra Rampazzo1 University of PaduaPaduaItaly
,
Annalisa Angelini1 University of PaduaPaduaItaly
,
Lucia Dal Bianco1 University of PaduaPaduaItaly
,
Massimo Padalino1 University of PaduaPaduaItaly
,
Giovanni Stellin1 University of PaduaPaduaItaly
&
Luciano Daliento1 University of PaduaPaduaItalyCorrespondence[email protected]
 show all
Pages 373-393 | Published online: 12 May 2010

Bibliography

  • Mitchell SC , KoronesSB, BerendesHW: Congenital heart disease in 56109 births incidence and natural history.Circulation, 43, 323–332 (1971).
  • Hoffman JIE : Incidence, mortality and natural history. In: Pediatric Cardiology. Anderson RH, Baker EJ, Macartney FJ et al. (Eds). Churchill Livingstone, London, UK 111–139 (2002).
  • Schultheiss TM , BurchJB, LassarAB: A role for bone morphogenetic proteins in the induction of cardiac myogenesis.Genes Dev., 11, 451–462 (1997).
  • Winnier G , BlessingM, LaboskyPA, HoganBL: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.Genes Dev., 9, 2105–2116 (1995).
  • Zhang H , BradleyA: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development.Development, 122, 2977–2986 (1996).
  • Monzen K , ShiojimaI, HiroiY, KudohS, OkaT, TakimotoE: Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4.Mol. Cell. Biol., 19, 7096–7105 (1999).
  • Lee KH , EvansS, RuanTY, LassarAB: SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer.Development, 131, 4709–4723 (2004).
  • Kasahara H , UshevaA, UeyamaT, AokiH, HorikoshiN, IzumoS:. Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein. J. Biol. Chem., 276, 4570–4580 (2001).
  • Kasahara H , IzumoS: Identification of the in vivo casein kinase II phosphorylation site within the homeodomain of the cardiac tissue specifying homeobox gene product Csx/Nkx2.5.Mol. Cell. Biol., 19, 526– 536 (1999).
  • Akazawa H , KomuroI: Cardiac transcription factor Csx/Nkx2.5: its role in cardiac development and disease.Pharmacol. Ther., 107, 252–268 (2005).
  • McAnally CJ , RichardsonJA, OlsonEN: Cardiac-specific activity of an Nkx-2.5 enhancer requires an evolutionarily conserved smad binding site.Dev. Biol., 244, 257–266 (2002).
  • Wu X , GoldenK, BodmerR: Heart development in Drosophila requires the segment polarity gene wingless.Dev. Biol., 169, 619–628 (1995).
  • Park M , WuX, GoldenK, AxelrodJD, BodmerR: The wingless signaling pathway is directly involved in Drosophila heart development.Dev. Biol., 177, 104–116 (1996).
  • Schneider VA , MercolaM: Wnt antagonism initiates cardiogenesis in Xenopus laevis.Genes Dev., 15, 304–315 (2001).
  • Pandur P , LascheM, EisenbergLM, KuhlM: Wnt-11 activation of a noncanonical Wnt signalling pathway is required for cardiogenesis.Nature, 418, 636–641 (2002).
  • Alfieri CM , CheekJ, ChakrabortyS, YutzeyKE: Wnt signaling in heart valve development and osteogenic gene induction.Dev. Biol., 338, 127–135 (2010).
  • Gisselbrecht S , SkeathJB, DoeCQ, MichelsonAM: Heartless encodes a fibroblast growth factor receptor (DFR1/DFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo.Genes Dev., 10, 3003–3017 (1996).
  • Amaya E , MusciTJ, KirschnerMW: Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos.Cell, 66, 257–270 (1991).
  • Azpiazu N , FraschM: Tinman and bagpipe – two homeobox genes that determine cell fates in the dorsal mesoderm of Drosophila.Genes Dev., 7, 1325–1340 (1993).
  • Baker R , SchubigerG: Ectoderm induces muscle specific gene expression in Drosophila embryos.Development, 121, 1387–1398 (1995).
  • Reifers F , WalshEC, LegerS, StainierDY, BrandM: Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar).Development, 127, 225–235 (2000).
  • Alsan BH , SchultheissTM: Regulation of avian cardiogenesis by FGF8 signaling.Development, 129, 1935–1943 (2002).
  • Meyers EN , MartinGR: Differences in left–right axis pathways in mouse and chick: function of FGF8 and SHH.Science, 285, 403–406 (1999).
  • Naito AT , TominagaA, OyamadaM, OyamadaY, ShiraishiI, MonzenK:Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002. Exp. Cell Res., 291, 56–69 (2003).
  • Kim Y , NirenbergM: Drosophila NK-homeobox genes.Proc. Natl Acad. Sci. USA, 86, 7716–7720 (1989).
  • Komuro I , IzumoS: Csx: a murine homeobox-containing gene specifically expressed in the developing heart.Proc. Natl Acad. Sci. USA, 90, 8145–8149 (1993).
  • Lints TJ , ParsonsLM, HartleyL, LyonsI, HarveyRP: Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants.Development, 119, 419–431 (1993).
  • Harvey RP : NK2 homeobox genes and heart development.Dev. Biol., 178, 203–216 (1996).
  • McElhinney DB , GeigerE, BlinderJ, BensonDW, GoldmuntzE: NKX2.5 mutations in patients with congenital heart disease.J. Am. Coll. Cardiol., 42, 1650–1655 (2003).
  • Ellitt D , SollowayM, WiseNet al.: A tyrosine-rich domain within homeodomain transcription factor Nkx2.5 is an essential element in the early cardiac transcriptional regulatory machinery.Development, 133, 1311–1322 (2006).
  • Kasahara H , BartunkovaS, SchinkeM, TanakaM, IzumoS: Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein.Circ. Res., 82, 936–946 (1998).
  • Stanley EG , BibenC, ElefantA, BarnettL, KoentgenF, RobbL: Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3´UTR-ires-Cre allele of the homeobox gene Nkx2–5.Int. J. Dev. Biol., 46, 431–439 (2002).
  • Thomas PS , KasaharaH, EdmonsonAM, IzumoS, Yacoub MH, Barton PJ: Elevated expression of Nkx-2.5 in developing myocardial conduction cells. Anat. Rec., 263, 307–313 (2001).
  • Lien CL , WuC, MercerB, WebbR, RichardsonJA, OlsonEN: Control of early cardiac-specific transcription of Nkx2–5 by a GATA-dependent enhancer.Development, 126, 75– 84 (1999).
  • Searcy RD , VincentEB, LiberatoreCM, YutzeyKE: A GATA-dependent Nkx-2.5 regulatory element activates early cardiac gene expression in transgenic mice.Development, 125, 4461–4470 (1998).
  • Reecy JM , LiX, YamadaM, DeMayoFJ, NewmanCS, HarveyRP: Identification of upstream regulatory regions in the heart-expressed homeobox gene Nkx2–5.Development, 126, 839–849 (1999).
  • Brown III CO, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz R J: The cardiac determination factor, Nkx2–5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J. Biol. Chem., 279, 10659–10669 (2004).
  • Pashmforoush M , LuJT, ChenH: Nkx2–5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leds to progressive cardiomyopathy and complete heart block.Cell, 117, 373–386 (2004).
  • Prall OW : An Nkx2.5/Bmp/Smad1 negative feedback loop controls heart progenitor specification e proliferation.Cell, 128, 947–959 (2007).
  • Molkentin JD : The zinc finger-containing transcription factors GATA-4, -5 and -6. Ubiquitously expressed regulators of tissue-specific gene expression.J. Biol. Chem., 275, 38949–38952 (2000).
  • Molkentin JD , LinQ, DuncanSA, OlsonEN: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.Genes Dev., 11, 1061–1072 (1997).
  • Kuo CT , MorriseyEE, AnandappaRet al.: GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.Genes Dev., 11, 1048–1060 (1997).
  • Reiter JF , AlexanderJ, RodawayAet al.: Gata5 is required for the development of the heart and endoderm in zebrafish.Genes Dev., 13, 2983–2995 (1999).
  • Morrisey EE , TangZ, SigristKet al.: GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo.Genes Dev., 12, 3579–3590 (1998).
  • Koutsourakis M , LangeveldA, PatientR, BeddingtonR, GrosveldF: The transcription factor GATA6 is essential for early extraembryonic development.Development, 126, 723–732 (1999).
  • Gajewski K , FossettN, MolkentinJD, SchulzRA: The zinc finger proteins Pannier and GATA4 function as cardiogenic factors in Drosophila.Development, 126, 5679–5688 (1999).
  • Searcy RD , VincentEB, LiberatoreCM, YutzeyKE: A GATA-dependent Nkx-2.5 regulatory element activates early cardiac gene expression in transgenic mice.Development, 125, 4461–4470 (1998).
  • Lien CL , WuC, MercerB, WebbR, RichardsonJA, OlsonEN: Control of early cardiac-specific transcription of Nkx2–5 by a GATA-dependent enhancer.Development, 126, 75–84 (1999).
  • Davis DL , WesselsA, BurchJB: An Nkx-dependent enhancer regulates GATA-6 gene expression during early stages of heart development.Dev. Biol., 217, 310–322 (2000).
  • Molkentin JD , AntosC, MercerB, TaigenT, MianoJM, OlsonEN: Direct activation of a GATA6 cardiac enhancer by Nkx2.5: evidence for a reinforcing regulatory network of Nkx2.5 and GATA transcription factors in the developing heart.Dev. Biol., 217, 301–309 (2000).
  • Garg V , KathiriyaIS, BarnesRet al.: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.Nature, 424, 443–447 (2003).
  • Okubo A , MiyoshiO, BabaKet al.: A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family.J. Med. Genet., 41, E97 (2004).
  • Rajagopal SK , MaQ, OblerDet al.: Spectrum of heart disease associated with murine and human GATA4 mutation.J. Mol. Cell. Cardiol., 43, 677–685 (2007).
  • Gajewski K , KimY, LeeYM, OlsonEN, SchulzRA: D-mef2 is a target for Tinman activation during Drosophila heart development.EMBO J., 16, 515–522 (1997).
  • Dodou E , VerziMP, AndersonJP, Xu S-M, Black BL: Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development, 131, 3931–3942 (2004).
  • Nguyen HT , BodmerR, AbmayrSM, McDermottJC, SpoerelNA: D-mef2:a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis.Proc. Natl Acad. Sci. USA, 91, 7520–7524 (1994).
  • Lilly B , GalewskyS, FirulliAB, SchulzRA, OlsonEN: D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis.Proc. Natl Acad. Sci. USA, 91, 5662–5666 (1994).
  • Lilly B , ZhaoB, RanganayakuluG, PatersonBM, SchulzRA, OlsonEN: Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila.Science, 267, 688–693 (1995).
  • Lin Q , SchwarzJ, BucanaC, OlsonEN: Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.Science, 276, 1404–1407 (1997).
  • Naya FJ , BlackBL, WuHet al.: Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.Nat. Med., 8, 1303–1309 (2002).
  • Moleketin JD , FirulliAB, BlackBLet al.: MEF2B is a potent transactivator expressed in early myogenic lineages.Mol. Cell. Biol., 16, 3814–3824 (1996).
  • Belaguli NS , SepulvedaJL, NigamV, CharronF, NemerM, SchwartzRJ: Cardiac tissue enriched factors serum response factor and GATA-4 are mutual co-regulators.Mol. Cell. Biol., 20, 7550–7558 (2000).
  • Wang D , ChangPS, WangZet al.: Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.Cell, 105, 851–862 (2001).
  • Shin C , LiuZ, PassierRet al.: Modulation of cardiac growth and development by HOP, an unusual homeodomain protein.Cell, 110, 725–735 (2002).
  • Chen F , KookH, MilewskiRet al.: Hop is an unusual homeobox gene that modulates cardiac development.Cell, 110, 713–723 (2002).
  • Parlakian A , TuilD, HamardGet al.: Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality.Mol. Cell. Biol., 24, 5281–5289 (2004).
  • Arsenian S , WeinholdB, OelgeschlagerM, RutherU, NordheimA: SRF is essential for mesoderm formation during mouse embryogenesis.EMBO J., 17, 6289–6299 (1998).
  • Weinhold B , ShrattG, ArsenianSet al.: SRF-/- ES cells display non-cell-autonomous impairment in mesodermal differentiation.EMBO J., 19, 5845–5844 (2000).
  • Firulli AB : A handful of questions: the molecular biology of the heart and neural crest derivatives (HAND)-subclass of basic helix-loop-helix transcription factors.Gene, 312, 27–40 (2003).
  • Srivastava D , ThomasT, LinQ, KirbyML, BrownD, OlsonEN: Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND.Nat. Genet., 16, 154–160 (1997).
  • Firulli AB , McFaddenDG, LinQ, SrivastavaD, OlsonEN: Heart and extra embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1.Nat. Genet., 18, 266–270 (1998).
  • Riley P , Anson-CartwrightL, CrossJC: The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.Nat. Genet., 18, 271–275 (1998).
  • Yamagishi H , YamagishiC, NakagawaO, HarveyRP, OlsonEN, SrivastavaD: The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.Dev. Biol., 239, 190–203 (2001).
  • Dai YS , CserjesiP, MarkhamBE, MolkentinJD: The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism.J. Biol. Chem., 277, 24390–24398 (2002).
  • Thattaliyath BD , FirulliBA, FirulliAB: The basic-helix-loop-helix transcription factor HAND2 directly regulates transcription of the atrial naturetic peptide gene.J. Mol. Cell. Cardiol., 34, 1335–1344 (2002).
  • Papaioannou VE , SilverLM: The T-box gene family.Bioessays, 20, 9–19 (1998).
  • Bruneau BG , LoganM, DavisNet al.: Chamber-specific cardiac expression of Tbx5 and heart defects in Holt–Oram syndrome.Dev. Biol., 211, 100–108 (1999).
  • Bruneau BG , NemerG, SchmittJPet al.: A murine model of Holt–Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.Cell, 106, 709–721 (2001).
  • Hiroi Y , KudohS, MonzenKet al.: Tbx5 associates with Nkx2–5 and synergistically promotes cardiomyocyte differentiation.Nat. Genet., 28, 276–280 (2001).
  • Plageman TF Jr, Yutzey KE: Differential expression and function of Tbx5 and Tbx20 in cardiac development. J. Biol. Chem., 279, 19026–19034 (2004).
  • Sinh MK , ChristoffelsVM, DiasJMet al.: Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2.Development, 132, 2697–2707 (2005).
  • Yamagagishi H , MaedaJ, UchidaKet al.: Molecular embryology for an understanding of congenital heart disease.Anat. Sci. Int., 84(3), 88–94 (2009).
  • Aruga J : The role of Zic genes in neural development.Mol. Cell. Neurosci., 26, 205–221 (2004).
  • Carrel T , PurandarSM, HarrisonWet al.: The X-linked mouse mutation Bent tail is associated with a deletion of the Zic3 locus.Hum. Mol. Genet., 9, 1937–1942 (2000).
  • Purandare SM , WareSM, KwanKMet al.: A complex syndrome of left–right axis, central nervous system and axial skeleton defects in Zic3 mutant mice.Development, 129, 2293–2302 (2002).
  • Aruga J : The role of Zic genes in neural development.Mol. Cell. Neurosci., 26, 205–221 (2004).
  • Carrel T , PurandarSM, HarrisonWet al.: The X-linked mouse mutation Bent tail is associated with a deletion of the Zic3 locus.Hum. Mol. Genet., 9, 1937–1942 (2000).
  • Purandare SM , WareSM, KwanKMet al.: A complex syndrome of left–right axis, central nervous system and axial skeleton defects in Zic3 mutant mice.Development, 129, 2293–2302 (2002).
  • Sweetman D , MunsterbergA: The vertebrate spalt genes in development and disease.Dev. Biol., 293, 285–293 (2006).
  • Koshiba-Takeuchi K , TakeuchiJK, ArrudaEPet al.: Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart.Nat. Genet., 38, 175–183 (2006).
  • Sakaki-Yumoto M , KobayashiC, SatoAet al.: The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in ano–rectal, heart, brain and kidney development.Development, 133, 3005–3013 (2006).
  • Leung MK , JonesT, MichelsCL, LivingstonDM, BhattacharyaS: Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1.Genomics, 61, 307–313 (1999).
  • Zhao F , LufkinT, GelbBD: Expression of Tfap2d, the gene encoding the transcription factor Ap-2 d, during mouse embryogenesis.Gene Exp. Patterns, 3, 213–217 (2003).
  • Bamforth S , BragancaJ, SchneiderJEet al.: Cited2 controls left–right patterning and heart development through a Nodal-Pitx2c pathway.Nat. Genet., 36, 1189–1195 (2004).
  • Bamforth SD : Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.Nat. Genet., 29, 469–474 (2001).
  • Weninger WJ , FloroKL, BennettMBet al.: Cited2 is required both for heart morphogenesis and establishment of the left–right axis in mouse development.Development, 132, 1337–1348 (2005).
  • Meyers EN , MartinGR: Difference in left–right axis pathways in mouse and chick: function of FGF8 and SHH.Science, 285, 403–406 (1999).
  • Schlange T , ArnoldHH, BrandT: Bmp2 is a positive regulator of nodal signaling during left–right axis formation in the chicken embryo.Development, 129, 3421–3429 (2002).
  • Kumar A , NovoselovV, CelesteAJ, WolfmannNM, DijkeP, KuehnMR: Nodal signaling uses activin and transforming growth factor-β receptor-regulated Smads.J. Biol. Chem., 276, 656–661 (2001).
  • Kitamura K , MiuraH, Miyagawa-TomitaSet al.: Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra and peri-ocular mesoderm and right pulmonary isomerism.Development, 126, 5749–5758 (1999).
  • Nowotschin S , LiaoJ, GagePJ, EpsteinJA, CampioneM, MorrowBE: Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field.Development, 133, 1565–1573 (2006).
  • Svensson EC , TuftsRL, PolkCE, LeidenJM: Molecular cloning of ZFPM2/FOG2:a modulator of transcription factor GATA4 in cardiomyocytes.Proc. Natl Acad. Sci. USA, 96, 956–961 (1999).
  • Svensson EC , HugginsGS, LinHet al.: A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding ZFPM2/FOG2.Nat. Genet., 25, 353–356 (2000).
  • Tevosian SG , DeconinckAE, TanakaMet al.: ZFPM2/FOG2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium.Cell, 101, 729–739 (2000).
  • Tanizawa Y , RiggsAC, Dagogo-JackSet al.: Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism.Diabetes, 43(7), 935–941 (1994).
  • Pfaff SL , MendelsohnM, StewartCL, EdlundT, JessellTM: Requirement for LIM Homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation.Cell, 84, 309–320 (1996).
  • Cai CL , LiangX, ShiYet al.: Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart.Dev. Cell, 5, 877–889 (2003).
  • Karlsson O , ThorS, NorbergT, OhlssonH, EdlundT: Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys–His domain.Nature, 344, 879–882 (1990).
  • Clark EB : Mechanisms in the pathogenesis of congenital heart disease. In: The Genetics of Cardiovascular Disease. Pierpont ME, Moller J (Eds). Martinus-Nijoff, Boston, MA, USA 3–11 (1986).
  • Clark EB : Pathogenetic mechanisms of congenital cardiovascular malformations revisited.Semin. Perinatol., 20, 465–472 (1996).
  • Rosenberg HS , OppenheimerEH, EsterlyJR: Congenital rubella syndrome: the late effects and their relation to early lesions.Perspect. Pediatr. Pathol., 6, 183–202 (1981).
  • Kumar SD , DheenST, TaySS: Maternal diabetes induces congenital heart defect in mice by altering the expression of genes involved in cardiovascular development.Cardiovasc. Diabetol., 6, 34 (2007).
  • Tikkanen J , HeinonenOP: Risk factors for cardiovascular malformations in Finland.Eur. J. Epidemiol., 6, 348–356 (1990).
  • Mazzanti L , CacciariE: Congenital heart disease in patients with Turner‘s syndrome. Italian study group for Turner syndrome.Clin. Endocrinol., 54, 69–73 (2001).
  • Korenberg JR , BradleyC, DistecheCM: Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis.Am. J. Hum. Genet., 50, 294–302 (1992).
  • Perez E , SullivanKE: Chromosome 22q11.2 deletion syndrome: DiGeorge and velocardiofacial syndromes.Curr. Opin. Pediatr., 14, 678–683 (2002).
  • Yagi H , FurutaniY, HamadaH: Role of TBX1 in human del22q11.2 syndrome.Lancet, 362, 1366–1373 (2003).
  • Lowery MC , MorrisCA, EwartA: Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients.Am. J. Hum. Genet., 57, 49–53 (1995).
  • Tartaglia M , MehlerEL, GoldbergR: Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.Nat. Genet., 29, 465–468 (2001).
  • Basson CT , CowleyGS, SolomonSD: The clinical and genetic spectrum of the Holt–Oram syndrome (heart-hand syndrome).N. Engl. J. Med., 330, 885–891 (1994).
  • McElhinney DB , KrantzJD, BasonL: Analysis of cardiovascular phenotype and genotype–phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome.Nat. Genet., 16, 235–242 (1997).
  • Satoda M , PieropontMEM, DiazGA: Mutations in TFAP2B cause Charge syndrome, a familial form of patent ductus arteriosus.Nat. Genet., 25, 42–46 (2000).
  • Vissers LE , van Ravenswaaij CM, Admiraal R: Mutations in a new member of the chromodomain gene family cause Charge syndrome. Nat. Genet., 36, 955–957 (2004).
  • Ruiz-Perez VL , IdeSE, StromTM: Mutations in a new gene for the Ellis–van Creveld syndrome and Weyers acrodental dysostosis.Nat. Genet., 24, 283–286 (2000).
  • Sanlaville D , GenevieveD, BernardinCet al.: Failure to detect an 8p22–8p23.1 duplication in patients with Kabuki (Niikawa–Kuroki) syndrome.Eur. J. Hum. Genet., 13, 690–693 (2005).
  • Engelen JJ , MoogU, EversJL: Duplicationof chromosome region 8p23.1-p23.3: a benign variant?Am. J. Med. Genet., 91, 18–21 (2000).
  • Nora JJ : Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic–environmental interaction.Circulation, 38, 604–617 (1968).
  • Jing-bin H , Ying-longL, Pei-WuS, Xiao-dongL, MingD, Xiang-MingF: Molecolar mechanisms of congenital heart disease.Cardiovasc. Pathol. DOI:10.1016/j.carpath.2009.06.008 (2009) (Epub ahead of print).
  • Bruneau G : The developmental genetics of congenital heart disease.Nature, 451, 943–948 (2008).
  • Bajolle F , ZaffranS, BonnetD: Genetics and embryological mechanisms of congenital heart diseases.Arch. Cardiovasc. Dis., 102, 59–63 (2009).
  • Pierpont ME , CraigT, BassonDet al.: Genetic basis for congenital heart defects: current knowledge.Circulation, 115, 3015–3038 (2007).
  • Bernier FP , SpaegensR: The geneticist‘s role in adult congenital heart disease.Cardiol. Clin., 24, 557–569 (2006).
  • Benson WD : The genetics of congenital heart disease: a point in the revolution.Cardiol. Clin., 20, 385–394 (2002).
  • Hartman JLT , GarvikB, Hartwell L: Principles for the buffe ring of genetics variation. Science, 291, 1001–1004 (2001).
  • Bentham J , BhattacharyaS: Genetic mechanisms controlling cardiovascular development.Ann. NY Acad. Sci., 1123, 10–19 (2008).
  • Van Beynemun IM , KapustaL, den Heijer M: Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur. Heart J., 27, 981–987 (2006).
  • Garg V , KathiriyaIS, BarnesRet al.: GATA4 mutations cause humancongenital heart defects and reveal an interaction with TBX5.Nature, 424, 443–447 (2003).
  • Lee Y , ShioiT, KasaharaH: The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression.Mol. Cell. Biol., 18, 3120–3129 (1998).
  • Sepulveda JL , BelaguliN, NigamV, ChenCY, NemerM, SchwartzRJ: GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression.Mol. Cell. Biol., 18, 3405–3415 (1998).
  • Ching YH , GhoshTK, CrossSJet al.: Mutation in myosin heavy chain 6 causes atrial septal defect.Nat. Genet., 37(4), 423–428 (2005).
  • Garg V , KathiriyaIS, BarnesRet al.: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.Nature, 424, 443–447 (2003).
  • Matsson H , EasonJ, BookwalterCSet al.: α-cardiac actin mutations produce atrial septal defects.Hum. Mol. Genet., 17, 256–265 (2008).
  • Schott JJ , BensonDW, BassonCTet al.: Congenital heart disease caused by mutations in the transcription factor NKX2–5.Science, 281, 108–111 (1998).
  • Shiojima I , KomuroI, InazawaJet al.:Assignment of cardiac homeobox gene CSX to human chromosome 5q34. Genomics, 27, 204–206 (1995).
  • Elliott DA , KirkEP, YeohTet al.: Cardiac homeobox gene NKX2–5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome.J. Am. Coll. Cardiol., 41, 2072–2076 (2003).
  • McElhinney DB , GeigerE, BlinderJ, BensonDW, GoldmuntzE: NKX2.5 mutations in patients with congenital heart disease.J. Am. Coll. Cardiol., 42, 1650–1655 (2003).
  • Posh M , PerrotA, SchmittKet al.: Mutations in GATA4, NKX2.5, CRELD1 and BMP4 are infrequently found in patients with congenital cardiac septal defects.Am J. Med. Genet.A, 146, 251–253 (2008).
  • Geiger E , BensonDW: NKX2.5 mutations in patients with tetralogy of Fallot.Circulation, 104, 2565–2568 (2001).
  • Zhang W , LiX, MaZet al.: GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart defect.Chin. Med. J., 122, 416–419 (2009).
  • Reamon-Buettner SM , BorlacJ: Somatic NKX2.5 mutations as a novel mechanism of disease in complex congenital heart disease.J. Med. Genet., 41, 684–690 (2004).
  • Draus JM , HauckMA, GoetschM, AustinEH, Tomita-MitchellA, MitchellME: Investigation of somatic NKX2.5 mutations in congenital heart disease.J. Med. Genet., 46, 115–122 (2009).
  • Hosoda T , KomuroI, ShiojimaIet al.: Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2–5 in a Japanese patient.Jpn Circ. J., 63, 425–426 (2009).
  • Kasahara H , LeeB, SchottJJet al.: Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease.J. Clin. Invest., 106, 299–308 (2000).
  • Zhu W , ShiojimaI, HiroiYet al.: Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease.J. Biol. Chem., 275, 35291–35296 (2000).
  • Monzen K , ZhuW, KasaiHet al.: Dual effects of the homeobox transcription factor Csx/Nkx2–5 on cardiomyocytes.Biochem. Biophys. Res. Commun., 298, 493–500 (2002).
  • Pauli RM , Scheib-WixtedS, CripeL, IzumoS, SekhonGS: Ventricular non-compaction and distal chromosome 5q deletion.Am. J. Med. Genet., 85, 419–423 (1999).
  • Garg V , KathiriyaIS, BarnesRet al.: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.Nature, 424, 443–447 (2003).
  • Rajagopal SK , MaQ, OblerDet al.: Spectrum of heart disease associated with murine and human GATA4 mutation.J. Mol. Cell. Cardiol., 43, 677–685 (2007).
  • Hirayam-Yamada K , KamisagoM, AkimotoKet al.: Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.Am. J. Med. Genet. A, 135, 47–52 (2005).
  • Sarkozy A , ContiE, NeriCet al.: Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors.J. Med. Genet., 42, E16 (2005).
  • Sarkozy A , EspositoG, ContiEet al.: CRELD1 and GATA4 gene analysis in patients with nonsyndromic atrioventricular canal defects.Am J. Med. Genet., 139(3), 236–238 (2005).
  • Nemer G , FadlalahF, UstaJet al.: A novel mutation in the GATA4 gene in patients with tetralogy of Fallot.Hum. Mutat., 27, 293–294 (2006).
  • Zhang L , TumerZ, JacobsenJR, AndersenPS, TommerupN, LarsenLA: Screening of 99 Danish patients with congenital heart disease for GATA4 mutations.Genet. Test., 10, 277–280 (2006).
  • Schluterman MK , KrysiakAE, KathiriyaISet al.: Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.Am. J. Med. Genet. A, 143A, 817–823 (2007).
  • Tomita-Mitchell A , MaslenCL, MorrisCD, GargV, GoldmuntzE: GATA4 sequence variants in patients with congenital heart disease.J. Med. Genet., 44, 779–783 (2007).
  • Zhang W , LiX, ShenA, JiaoW, GuanW, LiZ: GATA4 mutations in 486 Chinese patients with congenital heart disease.Eur. J. Med. Genet., 51, 527–535 (2008).
  • Sarkozy A , EspositoG, ContiEet al.: CRELD1 and GATA4 gene analysis in patients with nonsyndromic atrioventricular canal defects.Am. J. Med. Genet., 139(3), 236–238 (2005).
  • Reamon-Buettner SM , ChoSH, BorlakJ: Mutations in the 3´-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD).Med. Genet., 8, 38 (2007).
  • Kodoa K , NishizawaT, FurutanibMet al.: GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin–plexin signaling.Proc. Natl Acad. Sci. USA, 106, 33 (2009).
  • Casey B , DevotoM, JonesK, BallabioA: Mapping a gene for familial situs abnormalities to human chromosome Xq24–q27.1.Nat. Genet.403–407 (2003).
  • Defects of Laterality and Looping. Ferencz C, Loffredo CA, Correa-Villasenor A,Wilson PD (Eds). Futura Publishing, Armonk, NY, USA (2007).
  • Gebbia M , FerreroGB, PiliaGet al.: X-linked situs abnormalities result from mutations in ZIC3.Nat. Genet., 17, 305–308 (1997).
  • Megarbane A , SalemN, StephanEet al.: Xlinked transposition of the great arteries and incomplete penetrance among males with a nonsense mutation in ZIC3.Eur. J. Hum. Genet., 8, 704–708 (2000).
  • Ferrero GB , GebbiaM, PiliaGet al.: A submicroscopic deletion in Xq26 associated with familial situs ambiguus.Am. J. Hum. Genet., 61, 395–401 (1997).
  • Ware SM , PengJ, ZhuLet al.: Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects.Am. J. Hum. Genet., 74, 93–105 (2004).
  • Chhin B , HatayamaM, BozonDet al.: Elucidation of penetrance variability of a zic3 mutation in a family with complex heart defects and functional analysis of zic3 mutations in the first zinc finger domain.Hum. Mutat., 28(6), 563–570 (2007).
  • Kohlhase J , ChitayatD, KotzotDet al.: SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro–renal–ocular syndrome, and related disorders.Hum. Mutat., 26, 176–183 (2005).
  • Kohlhase J , HeinrichM, SchubertLet al.: Okihiro syndrome is caused by SALL4 mutations.Hum. Mol. Genet., 11, 2979–2987 (2002).
  • Kohlhase J , SchubertLet al., LiebersM : Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt–Oram syndrome, acro–renal–ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J. Med. Genet., 40, 473–478 (2003).
  • Borozdin W , WrightMJ, HennekamRCMet al.: Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum.J. Med. Genet., 41, E102 (2004).
  • Wang B , LiL, XieXet al.: Genetic variation of SAL-Like 4 (SALL4 ) in ventricular septal defect.Int. J. Cardiol. doi:10.1016/j.ijcard.2009.05.067 (2009) (Epub ahead of print).
  • Sperling S , GrimmCH, DunkelIet al.: Identification and functional analysis of CITED2 mutations in patients with congenital heart defects.Hum. Mutat., 26(6), 575–582 (2005).
  • Reamon-Buettner SM , CiribilliY, IngaA, BorlakJ: A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts.Hum. Mol. Genet., 17, 1397–1405 (2008).
  • Reamon-Buettner SM , CiribilliY, TraversoI, KuhlsB, IngaA, BorlakJ: A functional genetic study identifies HAND1 mutations in septation defects of the human heart.Hum. Mol. Genet., 18, 3567–3578 (2009).
  • Khetyar M , SyrrisP, TinworthL, AbushabanL, CarterN: Novel TFPA2B mutation in nonsindromic patent ductus arteriosus.Genet. Test., 12, 457–459 (2008).
  • Muncke N , NieslerB, RoethRet al.: Mutational analysis of the PITX2 coding region revealed no common cause for transposition of the great arteries (dTGA).BMC Med. Genet., 6, 20 (2005).
  • Pizzuti A , SarkozyA, NewtonALet al.: Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot.Hum. Mutat., 22, 372–377 (2003).
  • Sarkozy A , ContiE, D‘AgostinoRet al.: ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia.Am. J. Med. Genet., 133, 68–70 (2005).
  • Gong W , GottliebS, CollinsJet al.: Mutation analysis of Tbx1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects.J. Med. Genet., 38, E45 (2001).
  • Cabuk F , KarabulutHG, TuncaliT, KarademirS, BozdayiM, TükünA: TBX1 gene mutation screening in patients with non-syndromic Fallot Tetralogy.Turk. J. Pediatr., 49(1), 61–68 (2007).
  • Rauch R , HofbeckM, ZweierCet al.: Comprehensive genotype–phenotype analysis in 230 patients with Tetralogy of Fallot.J. Med. Genet. DOI: jmg.2009.070391 (2009) (Epub ahead of print).
  • Buettner SM , BorlakJ: TBX5 mutations in non-Holt–Oram syndrome (HOS) malformed hearts.Hum. Mutat., 24(1), 104 (2004).
  • Xin N , QiuGR, GongLG, XuXY, SunKL: The mechanism of TBX5 abnormal expression in simple congenital heart disease.Yi Chuan., 31(4), 374–380 (2009).
  • Kirk EP , SundeM, CostaMWet al.: Mutations in cardiac T-Box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy.Am. J. Hum. Genet., 81, 280–291 (2007).
  • Liu C , ShenA, LiX, JiaoW, ZhangX, LiZ: T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease.Eur. J. Med. Genet., 51, 580–587 (2008).
  • Megarbane O , DietzR, StillerBet al.: A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects.J. Med. Genet. doi: 10.1136/jmg.2009.069997 (2009) (Epub ahead of print).
  • Shiojima I , KomuroI: Cardiac developmental biology: from flies to humans.Jpn. J. Physiol., 55, 245–254 (2005).
  • Mandel EM , CallisTE, Wang D-Z, Conlon FL: Transcriptional Mechanisms of Congenital Heart Disease, 2(1), Elsevier (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.